Terminally sterile human Acellular Dermal Matrix (ADM) for plastic and reconstructive surgery procedures.
Intelligent Technology for Exceptional Results
Consistent Thicknesses
Provides optimal pliability.
Perforated
Facilitates fluid transfer and tissue integration.
Ready to Use
Eliminates the need for soaking, washing, or other preparation.
Clinically Proven
Comparable early safety data across Essence, AlloDerm and Cortiva.
When the Case Demands More.
Complex cases require more than coverage - they demand strength, consistency, and confidence you can rely on.
With its favorable biomechanical properties and advanced safety profile, Essence Acellular Dermal Matrix (ADM)® is an ideal choice for a wide range of clinical applications where soft tissue support or reinforment is required.
The Right Configuration for Your Procedure
Essence is available in two thicknesses, 0.8mm and 1.2mm, ensuring consistency and offering multiple shapes and sizes for seamless integration with your procedural needs.
Product
Shape
Size (cm)
Square CM
Thickness (mm)
Round
18x18 20x20
255 314
0.8 0.8, 1.22
Rectangle
8x16 16x20
128 320
0.8 0.8, 1.22
Shaped
10x18 10x20
134 146
0.8 0.8
Oval
20x24 24x26
377 491
0.8, 1.22 0.8, 1.22
Square
21x21 24x24
441 576
0.8, 1.22 1.22
Safety You Can Count On
Essence ADM is a product of donated human tissue obtained from accredited U.S. tissue banks that undergoes strict processing procedures.
Processing Steps:
Rigorous screening and testing.
Aseptic processing to remove the donor’s cells while preserving the integrity of the extracellular matrix proteins.
Terminal sterilization to an assurance level of (SAL) 10-6, which is the highest sterility level for surgical implants.
Resources
Explore more in-depth information, documentation, and data about Essence:
Bimini Health Tech empowers specialists to unlock each patient’s full potential. Our innovative solutions create the ideal conditions for healing, restoration, and renewed confidence.
Fair Balance Statement
Essence Acellular Dermal Matrix (ADM) implants are regulated as 361 Human Cell and Tissue Products (HCT/Ps) as defined in US FDA 21 CFR 1271, and are restricted to homologous use for the repair, replacement, reconstruction or augmentation of soft tissue by a qualified healthcare professional (e.g., physician).
